Ontogen Medtech Achieves ISO 13485 Certification, Strengthening Contract Manufacturing Capabilities
ISO 13485 certification demonstrates that Ontogen's quality management system meets rigorous international standards governing the production of medical devices. "Achieving ISO 13485 certification is a pivotal step in Ontogen's growth," said
With this certification, Ontogen is now uniquely positioned to provide end-to-end support for its clients, from concept and prototyping to pilot production and full-scale contract manufacturing. The company's
"Medical device companies need more than just design expertise," added
The certification also highlights Ontogen's role as a collaborative hub for medtech innovation. Beyond contract manufacturing, the company provides design services, regulatory strategy, commercialization support & fulfillment services, and offers subleased office space to startup clients, helping accelerate their path to market while reducing capital burden.
For clients, ISO 13485 certification translates into:
- Stronger regulatory alignment with FDA, EU MDR, and other global requirements.
- Enhanced risk management and product safety throughout the development lifecycle.
- Streamlined path to market with compliant manufacturing and documentation practices.
- Scalable production capacity to support growth from pilot lots to commercial supply.
Ontogen's achievement signals not only an internal milestone but also an industry-wide commitment to advancing patient care. As the demand for innovative medical technologies grows, the ability to provide certified, high-quality manufacturing services will be essential for companies bringing new devices to market.
About Ontogen Medtech
Ontogen Medtech is a full-service medical device design and development firm based in
Media Contact:
Principal, Co-Founder
Ontogen Medtech
630-384-9430
[email protected]
View original content to download multimedia:https://www.prnewswire.com/news-releases/ontogen-medtech-achieves-iso-13485-certification-strengthening-contract-manufacturing-capabilities-302573435.html
SOURCE Ontogen Medtech LLC
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Otus Earns 2026 CODiE Award for Best Evidence Management Solution
- /C O R R E C T I O N -- Overlord Labs/
- Raymond Douglas, MD, PhD, Is First in the Nation to Infuse Newly FDA-Approved Thyroid Eye Disease Treatment, LUMVOA ™ (veligrotug-vvze)
Create E-mail Alert Related Categories
PRNewswire, Press ReleasesRelated Entities
FDASign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share